Endece
Endece was founded in 2006, is headquartered in Cedarburg, United States, lists 1–10 employees, and has $225K in recorded funding across 1 round.
- Headquarters
- Cedarburg, Wisconsin
- Employees
- 1–10
- Founded
- 2006
- Website
- endece.com
- Total Funding
- $225K
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
ENDECE is a drug discovery and development company focused on treatments for neurodegenerative disease, led by President Dr. James Yarger. Its lead candidate, NDC-1308, has a unique dual mechanism of action that directly induces remyelination of demyelinated axons within the central nervous system while also protecting against further demyelination, differentiating it from other multiple sclerosis therapies. NDC-1308 also upregulates the gene for lipoprotein lipase within macrophages, driving their polarization toward an anti-inflammatory, pro-repair state. The company's stated mission is to develop treatments that stop disease progression, restore function, and improve patients' quality of life.
Summary
Endece is a Biotech company based in Cedarburg, United States, founded in 2006. It lists 1–10 employees. It has raised $225K in total across 1 round.
Funding History
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/endece"><img src="https://indexed.vc/api/badge/company/endece" alt="Endece on Indexed.vc" width="260" height="76" /></a>